Next Article in Journal
The Role of Viscosity and Fermentability of Dietary Fibers on Satiety- and Adiposity-Related Hormones in Rats
Next Article in Special Issue
Vitamin D Levels Are Associated with Cardiac Autonomic Activity in Healthy Humans
Previous Article in Journal
The Effects of Caffeinated “Energy Shots” on Time Trial Performance
Previous Article in Special Issue
Vitamin D and the Athlete: Risks, Recommendations, and Benefits
Open AccessArticle

Effects of Vitamin D3 and Paricalcitol on Immature Cardiomyocytes: A Novel Role for Vitamin D Analogs in the Prevention of Cardiovascular Diseases

1
Department of Experimental and Clinical Medicine, University of Firenze, 50134 Firenze, Italy
2
Division of Nephrology and Hemodialysis, Prato Hospital, 59100 Prato, Italy
3
Department of Biomedical, Experimental and Clinical Sciences, University of Firenze, 50134 Firenze, Italy
*
Author to whom correspondence should be addressed.
Nutrients 2013, 5(6), 2076-2092; https://doi.org/10.3390/nu5062076
Received: 15 April 2013 / Revised: 23 May 2013 / Accepted: 24 May 2013 / Published: 7 June 2013
(This article belongs to the Special Issue Vitamin D and Human Health)
Cardiovascular diseases are more prevalent in patients with chronic kidney disease than in the general population and they are considered the leading cause of death in patients with end-stage renal disease. The discovery that vitamin D3 plays a considerable role in cardiovascular protection has led, in recent years, to an increase in the administration of therapies based on the use of this molecule; nevertheless, several studies warned that an excess of vitamin D3 may increase the risk of hypercalcemia and vascular calcifications. In this study we evaluated the effects of vitamin D3, and of its selective analog paricalcitol, on immature cardiomyocytes. Results show that vitamin D3 induces cAMP-mediated cell proliferation and significant intracellular calcification. Paricalcitol, however, induces cell differentiation, morphological modifications in cell shape and size, and no intracellular calcification. Furthermore, vitamin D3 and paricalcitol differently affect cardiomyoblasts responses to acetylcholine treatment. In conclusion, our results demonstrate that the effects of vitamin D3 and paricalcitol on cardiomyoblasts are different and, if these in vitro observations could be extrapolated in vivo, they suggest that paricalcitol has the potential for cardiovascular protection without the risk of inducing intracellular calcification. View Full-Text
Keywords: vitamin D3; paricalcitol; GcMAF; cardiomyocytes; kidney disease vitamin D3; paricalcitol; GcMAF; cardiomyocytes; kidney disease
Show Figures

Figure 1

MDPI and ACS Style

Pacini, S.; Morucci, G.; Branca, J.J.V.; Aterini, S.; Amato, M.; Gulisano, M.; Ruggiero, M. Effects of Vitamin D3 and Paricalcitol on Immature Cardiomyocytes: A Novel Role for Vitamin D Analogs in the Prevention of Cardiovascular Diseases. Nutrients 2013, 5, 2076-2092.

Show more citation formats Show less citations formats

Article Access Map by Country/Region

1
Only visits after 24 November 2015 are recorded.
Back to TopTop